EP2175861
Pharmaceutical combination of naproxen with 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.7.2008EP published:
20.8.2014EP application number:
08778018.5
EPO information:
European Patent Register
Max expiry date:
2.7.2028
Title:
Pharmaceutical combination of naproxen with 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1
Timeline
Today
3.7.2008EP application
20.8.2014EP Publication
Owner
Name:
Sucampo AGAddress:
Baarerstrasse 22, 6300, Zug, CH
Inventor
Name:
UENO, RyujiAddress:
Montgomery, Maryland, US
Priority
Number:
929557 PDate:
3.7.2007Country:
US
Number:
37517Date:
18.3.2008Country:
US
Classification
Categories:
A61K 45/06, A61K 31/557, A61K 31/192, A61K 31/20, A61P 1/04, A61P 29/00, A61P 25/28, A61P 35/00